Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
9.01
+0.01 (0.11%)
At close: Sep 26, 2025, 4:00 PM EDT
9.02
+0.01 (0.11%)
After-hours: Sep 26, 2025, 4:04 PM EDT
Anika Therapeutics Employees
Anika Therapeutics had 288 employees as of December 31, 2024. The number of employees decreased by 69 or -19.33% compared to the previous year.
Employees
288
Change (1Y)
-69
Growth (1Y)
-19.33%
Revenue / Employee
$397,736
Profits / Employee
-$210,507
Market Cap
130.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ANIK News
- 22 days ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts - Seeking Alpha
- 2 months ago - Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Anika Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update - GlobeNewsWire
- 2 months ago - Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 - GlobeNewsWire
- 5 months ago - Anika Therapeutics, Inc. (ANIK) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Anika Reports First Quarter 2025 Financial Results - GlobeNewsWire